Federal Register
Monday October 19, 2009

Planning to Submit Comments?

Documents and comments received by the Division of Dockets Management may be posted on the Internet. Please do not include personal identifying information, i.e. date of birth, social security number, medical information, etc., in your correspondence.
Submit Electronic Comments

Documents are on display for public inspection at the Division of Dockets Management, 5630 Fishers Lane (Room 1061), HFA-305, Rockville, MD, 20852; 301-827-6860; TTY/TDD Users 1-800-735-2258.

---

FDA Federal Register Documents

NOTICES-FINAL GUIDANCES

Docket No. FDA-2007-D-0302 (formerly Docket No. 2007D-0185), CDER 2008147.  Guidance for Industry and Review Staff on Labeling for Human Prescription Drug and Biological Products--Determining Established Pharmacologic Class for Use in the Highlights of Prescribing Information; Availability.  Pages  53507-53508 [FR Doc. E9-24991]  [OFR PUB]

NOTICES

Docket No. FDA-2009-N-0143, CDER 2009104.  Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Public Meeting; Reopening of Comment Period (Notice; reopening of comment period).  Pages  53509-53510 [FR Doc. E9-25022]  [OFR PUB] Comments due October 19, 2010

---

Table of Contents for Entire Federal Register
Monday, October 19, 2009 [Not Available]